speb/financial-data huggingface dataset:
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 252500000.00
NOVARTIND.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 1296600000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 931800000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 252500000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Net Interest Income: 700000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: 12600000.00
NOVARTIND.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -200200000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: 700000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 12600000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Net PPE: 28800000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 28800000.00
NOVARTIND.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -3200000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 8178300000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 8178300000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 134700000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 134700000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1327700000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 305600000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Normalized Income: 931081351.23
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 251913570.01
NOVARTIND.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 467300000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Operating Income: 920200000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Operating Income: 201300000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Operating Revenue: 3543300000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 905500000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 24690797.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 24690797.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 95300000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 95300000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 35900000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 35900000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 8054900000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 8054900000.00
NOVARTIND.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -374100000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 737700000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 737700000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 374700000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 86800000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 409100000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 134700000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Other Properties: 28800000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 28800000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 6158500000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 6158500000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Other Special Charges: 300000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Payables: 709400000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Payables: 709400000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Pretax Income: 1296600000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 301400000.00
NOVARTIND.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 1200000.00
NOVARTIND.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -17390200000.00
NOVARTIND.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -3400000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 1983700000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 521800000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 19500000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 4200000.00
NOVARTIND.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 17190000000.00
NOVARTIND.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 200000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Share Issued: 24690797.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 24690797.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Special Income Charges: 1000000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 700000.00
NOVARTIND.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 2700000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 8178300000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 8178300000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 8178300000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 8178300000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 281351.23
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 113570.01
NOVARTIND.NS income_statement (annual, 2026-03-31) — Tax Provision: 364800000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 48900000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.28
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.16
NOVARTIND.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -352600000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Total Assets: 9782700000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 9782700000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 8178300000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 8178300000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Total Debt: 32100000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 32100000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 8178300000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 8178300000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Total Expenses: 2623100000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 704200000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 1604400000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1604400000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 2100200000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 2100200000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 154700000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 154700000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 162900000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 162900000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 1000000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 700000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 1000000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 700000.00
NOVARTIND.NS balance_sheet (annual, 2026-03-31) — Working Capital: 6232800000.00
NOVARTIND.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 6232800000.00
NOVARTIND.NS income_statement (annual, 2026-03-31) — Write Off: -1300000.00
NOVARTIND.NS income_statement (quarterly, 2026-03-31) — Write Off: -700000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — +Operating Expense: 136200000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — +Total Revenue: 1038100000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Basic Average Shares: 24681992.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Basic EPS: 13.05
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Cost Of Revenue: 556700000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Depreciation And Amortization In Income Statement: 4200000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Depreciation Income Statement: 4200000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 24681992.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Diluted EPS: 13.05
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Diluted NI Availto Com Stockholders: 322100000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — EBIT: 432300000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — EBITDA: 436500000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Gross Profit: 481400000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Interest Expense: 600000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Interest Expense Non Operating: 600000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Net Income: 322100000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Net Income Common Stockholders: 322100000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Net Income Continuous Operations: 322100000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing And Discontinued Operation: 322100000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing Operation Net Minority Interest: 322100000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Net Income Including Noncontrolling Interests: 322100000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Net Interest Income: -600000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Net Non Operating Interest Income Expense: -600000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Normalized EBITDA: 436800000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Normalized Income: 322323836.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Operating Income: 345200000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Operating Revenue: 1038100000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Other Non Operating Income Expenses: 87400000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Other Operating Expenses: 84800000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Otherunder Preferred Stock Dividend: 0.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Pretax Income: 431700000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Reconciled Cost Of Revenue: 556700000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Reconciled Depreciation: 4200000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Special Income Charges: -300000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Tax Effect Of Unusual Items: -76164.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Tax Provision: 109600000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Tax Rate For Calcs: 0.25
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Total Expenses: 692900000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Total Unusual Items: -300000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Total Unusual Items Excluding Goodwill: -300000.00
NOVARTIND.NS income_statement (quarterly, 2026-06-30) — Write Off: 300000.00
NOVN.SW cash_flow (annual, 2021-12-31) — Cash From Discontinued Financing Activities: 26000000.00
NOVN.SW cash_flow (annual, 2021-12-31) — Cash From Discontinued Investing Activities: -689000000.00
NOVN.SW cash_flow (annual, 2021-12-31) — Cash From Discontinued Operating Activities: 1706000000.00
NOVN.SW balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 123000000.00
NOVN.SW balance_sheet (annual, 2021-12-31) — Current Deferred Revenue: 123000000.00
NOVN.SW balance_sheet (annual, 2021-12-31) — Held To Maturity Securities: 34000000.00
NOVN.SW cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 16000000.00
NOVN.SW income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 1113000000.00
NOVN.SW balance_sheet (annual, 2021-12-31) — Non Current Note Receivables: 78000000.00
NOVN.SW balance_sheet (annual, 2021-12-31) — Other Current Assets: 2718000000.00
NOVN.SW balance_sheet (annual, 2021-12-31) — Other Equity Adjustments: -4187000000.00
NOVN.SW balance_sheet (annual, 2021-12-31) — Other Investments: 366000000.00
NOVN.SW balance_sheet (annual, 2021-12-31) — Other Payable: 588000000.00
NOVN.SW cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 53000000.00
NOVN.SW cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: 806000000.00
NOVN.SW balance_sheet (annual, 2021-12-31) — Retained Earnings: 70989000000.00
NOVN.SW income_statement (annual, 2022-12-31) — +Operating Expense: 23933000000.00
NOVN.SW income_statement (annual, 2022-12-31) — +Total Revenue: 43461000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Accounts Payable: 5146000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Accounts Receivable: 8066000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -14109000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -62000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 5061000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 5061000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Amortization Of Securities: 260000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 865000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Basic Average Shares: 2181000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Basic EPS: 3.19
NOVN.SW cash_flow (annual, 2022-12-31) — Beginning Cash Position: 12407000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 12141000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Capital Expenditure: -2239000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1789000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Capital Stock: 890000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 7517000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 18615000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -7506000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Cash Equivalents: 4640000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Cash Financial: 2877000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -20681000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 1904000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 13039000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Cash From Discontinued Financing Activities: 119000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Cash From Discontinued Investing Activities: -436000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Cash From Discontinued Operating Activities: 1197000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Change In Account Payable: -181000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Change In Inventory: -560000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -84000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 426000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Change In Payable: -181000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -181000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Change In Receivables: -397000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Change In Working Capital: -796000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -397000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Changes In Cash: -4858000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Commercial Paper: 2772000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Common Stock: 890000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -7506000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Common Stock Equity: 59342000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Common Stock Payments: -10652000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Construction In Progress: 1184000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Cost Of Revenue: 11582000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 1942000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Current Assets: 36910000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 251000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Current Debt: 5876000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 6127000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 123000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 123000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Current Liabilities: 28656000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Current Provisions: 8464000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Deferred Income Tax: 1128000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Deferred Tax: 1128000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 491000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Depreciation: 1644000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 6705000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 6705000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Diluted Average Shares: 2197000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Diluted EPS: 3.17
NOVN.SW income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 6955000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 1000000.00
NOVN.SW income_statement (annual, 2022-12-31) — EBIT: 7977000000.00
NOVN.SW income_statement (annual, 2022-12-31) — EBITDA: 14682000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Earnings From Equity Interest: -11000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 11000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -32000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Employee Benefits: 2639000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — End Cash Position: 7517000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 598000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Financing Cash Flow: -20562000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Finished Goods: 2568000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Free Cash Flow: 11997000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -308000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -184000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -4996000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Goodwill: 29301000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 60945000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 8128000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Gross PPE: 26304000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Gross Profit: 31879000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 315000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 37000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Income Tax Payable: 2533000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Interest Expense: 800000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 800000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Interest Income: 377000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Interest Income Non Operating: 377000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -667000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Interest Payable: 116000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Interest Received Cfo: 252000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Inventory: 7175000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Invested Capital: 85462000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Investing Cash Flow: 1468000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 1463000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Investments And Advances: 1606000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 143000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Issuance Of Debt: 252000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Land And Improvements: 956000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Line Of Credit: 863000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 1538000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Long Term Debt: 20244000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 21782000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 16000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -262000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 143000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Long Term Provisions: 689000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 11959000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Minority Interest: 81000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Minority Interests: 0.00
NOVN.SW cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -864000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -10652000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Net Debt: 18603000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Net Income: 6955000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 6955000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 6049000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 906000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 6955000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 6049000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 6049000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 6955000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -1153000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Net Interest Income: -574000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 4680000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -2585000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -262000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -574000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -38000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -1000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Net PPE: 12195000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -758000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -2323000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -1603000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 863000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 4158000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 2686000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 3739000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 2686000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Non Current Note Receivables: 85000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2085000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Normalized EBITDA: 14866000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Normalized Income: 6204112000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Operating Cash Flow: 14236000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Operating Gains Losses: -297000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Operating Income: 7946000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Operating Revenue: 42206000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 2119609057.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Other Current Assets: 2739000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 2241000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 186000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -4996000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Other Income Expense: -195000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 31644000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Other Investments: 281000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Other Non Cash Items: -3000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 200000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1578000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Other Operating Expenses: 2568000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Other Payable: 743000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Other Properties: 64000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Other Receivables: 1001000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 11098000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Payables: 9258000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 11200000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2556000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Prepaid Assets: 911000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Pretax Income: 7177000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 100000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Properties: 0.00
NOVN.SW cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 1318000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -1323000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Purchase Of Investment: -34810000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Purchase Of PPE: -916000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Raw Materials: 934000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Receivables: 9894000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 11582000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Reconciled Depreciation: 6705000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Repayment Of Debt: -2837000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -10652000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Research And Development: 9172000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Retained Earnings: 63540000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Sale Of Intangibles: 170000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Sale Of Investment: 39490000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Sale Of PPE: 158000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Selling General And Administration: 12193000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Share Issued: 2403721252.00
NOVN.SW cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 252000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -2575000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Stock Based Compensation: 791000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Stockholders Equity: 59342000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Tangible Book Value: -1603000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -28888000.00
NOVN.SW income_statement (annual, 2022-12-31) — Tax Provision: 1128000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.16
NOVN.SW balance_sheet (annual, 2022-12-31) — Taxes Receivable: 827000000.00
NOVN.SW cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -1702000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Total Assets: 117453000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Total Capitalization: 79586000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Total Debt: 27909000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 59423000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Total Expenses: 35515000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 58030000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 80543000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 29374000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 7946000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Total Other Finance Cost: 151000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Total Tax Payable: 3369000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Total Unusual Items: -184000000.00
NOVN.SW income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -184000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 284112195.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Treasury Stock: 92000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Work In Process: 3673000000.00
NOVN.SW balance_sheet (annual, 2022-12-31) — Working Capital: 8254000000.00
NOVN.SW income_statement (annual, 2023-12-31) — +Operating Expense: 24419000000.00
NOVN.SW income_statement (annual, 2023-12-31) — +Total Revenue: 46660000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Accounts Payable: 4926000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Accounts Receivable: 7107000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -11879000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -51000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 7008000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 7008000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Amortization Of Securities: 106000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 1115000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Basic Average Shares: 2076794140.00
NOVN.SW income_statement (annual, 2023-12-31) — Basic EPS: 7.15
NOVN.SW cash_flow (annual, 2023-12-31) — Beginning Cash Position: 7517000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 10896000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Capital Expenditure: -2753000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 1828000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Capital Stock: 825000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 13393000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 13962000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -7255000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Cash Equivalents: 10186000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Cash Financial: 3207000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -17564000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 6719000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 14220000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Cash From Discontinued Financing Activities: 3286000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Cash From Discontinued Investing Activities: -1123000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Cash From Discontinued Operating Activities: 238000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Change In Account Payable: 479000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Change In Inventory: -546000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -125000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 1327000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Change In Payable: 479000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 479000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Change In Receivables: -1504000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Change In Working Capital: -369000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -1504000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Changes In Cash: 5776000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Commercial Paper: 3269000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Common Stock: 825000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -7255000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Common Stock Equity: 46667000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Common Stock Payments: -8719000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Construction In Progress: 1213000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Cost Of Revenue: 12472000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 1986000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Current Assets: 30481000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 230000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Current Debt: 6084000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 6314000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 98000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 98000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Current Liabilities: 26390000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Current Provisions: 7080000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Deferred Income Tax: 551000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Deferred Tax: 551000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 545000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Depreciation: 1269000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 8277000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 8277000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Diluted Average Shares: 2092000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Diluted EPS: 7.10
NOVN.SW income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 14850000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Dividend Received Cfo: 2000000.00
NOVN.SW income_statement (annual, 2023-12-31) — EBIT: 9978000000.00
NOVN.SW income_statement (annual, 2023-12-31) — EBITDA: 18255000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -13000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 13000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 100000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Employee Benefits: 2730000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — End Cash Position: 13393000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 507000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Financing Cash Flow: -14278000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Finished Goods: 1448000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Free Cash Flow: 11705000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -180000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -214000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -3766000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Goodwill: 23341000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 50220000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 7158000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Gross PPE: 22803000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Gross Profit: 34188000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 466000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 29000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Income Tax Payable: 1893000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Interest Expense: 855000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 855000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Interest Income: 627000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Interest Income Non Operating: 627000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Interest Paid Cfo: -751000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Interest Payable: 116000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Interest Received Cfo: 645000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Inventory: 5913000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Invested Capital: 71187000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Investing Cash Flow: 5596000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 1622000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Investments And Advances: 1827000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 205000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Issuance Of Debt: 546000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Land And Improvements: 886000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Line Of Credit: 624000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1598000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Long Term Debt: 18436000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 20034000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -258000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 205000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Long Term Provisions: 600000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 9742000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Minority Interest: 83000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Minority Interests: -4000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -3558000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -8719000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Net Debt: 11127000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Net Income: 14850000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 14850000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 8572000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: 6282000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 14850000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 8568000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 8572000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 14854000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 262000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Net Interest Income: -419000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 10849000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -1935000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -258000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -419000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 345000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -11000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Net PPE: 10924000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -823000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -1677000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -3553000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 871000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 4748000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 2248000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 4309000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 2248000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Non Current Note Receivables: 114000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2184000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Normalized EBITDA: 18469000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Normalized Income: 8769160000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Operating Cash Flow: 14458000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Operating Gains Losses: -167000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Operating Income: 9769000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Operating Revenue: 45440000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 2044033986.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 2191000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 105000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -3766000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Other Income Expense: -227000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 26879000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Other Investments: 190000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Other Non Cash Items: -785000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 215000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1193000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Other Operating Expenses: 531000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Other Payable: 820000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Other Properties: 66000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Other Receivables: 1317000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 569000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Payables: 8155000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 10141000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2652000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Prepaid Assets: 764000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Pretax Income: 9123000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 153000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Properties: 0.00
NOVN.SW cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 61000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Purchase Of Business: -3561000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -1693000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Purchase Of Investment: -747000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Purchase Of PPE: -1060000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Raw Materials: 963000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Receivables: 9376000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 12472000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Reconciled Depreciation: 8277000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Repayment Of Debt: -2481000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -8719000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Research And Development: 11371000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Retained Earnings: 49649000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Sale Of Business: 3000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Sale Of Intangibles: 1955000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Sale Of Investment: 11596000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Sale Of PPE: 237000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Selling General And Administration: 12517000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Share Issued: 2277477752.00
NOVN.SW cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 546000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -2223000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Stock Based Compensation: 865000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Stockholders Equity: 46667000000.00
NOVN.SW balance_sheet (annual, 2023-12-31) — Tangible Book Value: -3553000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -12840000.00
NOVN.SW income_statement (annual, 2023-12-31) — Tax Provision: 551000000.00
NOVN.SW income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.06
NOVN.SW balance_sheet (annual, 2023-12-31) — Taxes Receivable: 952000000.00
NOVN.SW cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -2787000000.00